Hi, what are you looking for?
Jewish Business News
Search results for "Mylan"
Business
– The European Patent Office ruled in favor of Teva in a patent opposition proceeding filed by Synthon and Mylan. – Please help...
Money
– Teva investors are concerned about competition to the company’s Copaxone medication now that its patent has expired. Due to its failed attempt recently...
Business
– Mylan CEO Heather Bresch: Teva’s suit against the FDA was simply a desperate, last minute tactic. – – “We continue to see no...
Business
– “Bloomberg” says investors are wondering how long Teva can stay out of the game. “Drugmakers on an acquisition spree have created...
Court
– The US Supreme Court has in effect allowed generic versions of the MS drug from next month. – – Teva Pharmaceutical Industries Ltd. TEVATEVA (NYSE: ;...
Court
– – The US Supreme Court has agreed to hear an appeal by Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) over the expiry of its patents for...
Court
– A federal judge in Virginia ruled that the patent for Pfizer’s Celebrex expires in May. – A US federal judge in Virginia has...
Court
– In July, the US Court of Appeals upheld a lower court decision invalidating four patents on the blockbuster MS treatment. – – Reuters...
Court
– The District Court of the Hague (Netherlands) rejected a patent revocation suit brought by Mylan’s Dutch unit. – – The District Court of...
Court
– Teva Pharmaceutical Industries Ltd. has chalked up a victory in the UK against Mylan Inc., stating that their Copaxone patents are valid through...